RxDoctor Payments Data

Matthew Greer, MD

Radiation Oncology · Tucson, AZNPI 1073045043

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $952, 3.8 times the $251 reported in 2021. That places this record below the midpoint for radiation oncology clinicians in AZ, where the typical reported total is $1,482.

$1,809in general payments, 2019–2025

Across 56 payments — averaging $32.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$229
  • Novartis$174
  • Merck$168
  • IBA Proton Therapy, Inc.$134
  • Histosonics, Inc.$97
  • Lilly USA, LLC$95
  • plus $913 from 28 others

What the payments were for

  • Food & beverage$1,809100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,809 in reported general payments places this provider in the 50th percentile of 138 radiation oncology providers in Arizona.

See all radiation oncology providers in Arizona →

Medicare billing

Part B allowed, 2024
$117,190
Medicare patients
149
Services billed
1,304

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone12$322
SsdSilver Sulfadiazine11$98
Lidocaine Hcl ViscousLidocaine Hcl11$78

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Tucson

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →